Newly diagnosed adults with CP Ph+ CML

BFORE=Bosutinib Trial in First-Line Chronic Myelogenous Leukemia Treatment; NCCN=National Comprehensive Cancer Network; Ph+=Philadelphia chromosome–positive.
Reference
1. BOSULIF Prescribing Information. New York, NY: Pfizer Inc.